These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 12473209)
1. Infections following allogeneic stem cell transplantation: New concepts, improved insights, and renewed hope for better outcomes. Kontoyiannis DP Virulence; 2016 Nov; 7(8):898-900. PubMed ID: 27791470 [No Abstract] [Full Text] [Related]
2. Immune reconstitution and survival of patients after allogeneic hematopoietic stem cell transplantation from older donors. Jiang P; Cai Y; Zhou X; Yang J; Tong Y; Huang C; Qiu H; Zhou K; Xu X; Zhang Y; Niu J; Shen C; Xia X; Wei Y; Song X; Wan L Clin Transplant; 2023 Jan; 37(1):e14844. PubMed ID: 36318732 [TBL] [Abstract][Full Text] [Related]
3. Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation. Elmariah H; Brunstein CG; Bejanyan N Life (Basel); 2021 Jan; 11(2):. PubMed ID: 33572932 [TBL] [Abstract][Full Text] [Related]
4. Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia. Varda-Bloom N; Danylesko I; Shouval R; Eldror S; Lev A; Davidson J; Rosenthal E; Volchek Y; Shem-Tov N; Yerushalmi R; Shimoni A; Somech R; Nagler A Oncotarget; 2017 Jan; 8(1):418-429. PubMed ID: 27880933 [TBL] [Abstract][Full Text] [Related]
5. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report. Gea-Banacloche J; Komanduri KV; Carpenter P; Paczesny S; Sarantopoulos S; Young JA; El Kassar N; Le RQ; Schultz KR; Griffith LM; Savani BN; Wingard JR Biol Blood Marrow Transplant; 2017 Jun; 23(6):870-881. PubMed ID: 27751936 [TBL] [Abstract][Full Text] [Related]
6. Donor-derived constitutional chromosomal abnormalities after allogeneic hematopoietic cell transplantation: a single-center experience and a review of the literature. Nishihori T; El-Asmar J; Shah B; Hussaini M; Komrokji R; List A; Anasetti C; Kharfan-Dabaja MA Bone Marrow Transplant; 2015 Oct; 50(10):1388-92. PubMed ID: 26191951 [No Abstract] [Full Text] [Related]
7. Assessment of immune reconstitution status in recipients of a successful hematopoietic stem cell transplant from peripheral blood after reduced intensity conditioning. Jaime-Pérez JC; Villarreal-Villarreal CD; Méndez-Ramírez N; Vázquez-Garza E; Salazar-Riojas R; Gómez-Almaguer D Blood Cells Mol Dis; 2016 May; 58():52-6. PubMed ID: 27067489 [TBL] [Abstract][Full Text] [Related]
8. [Inactivation of allogeneic stem cells by T and B lymphocytes]. Man'ko VM; Rudneva TB Dokl Akad Nauk SSSR; 1975; 220(1):213-5. PubMed ID: 234367 [No Abstract] [Full Text] [Related]
9. Successful outcome in two patients with CD40 deficiency treated with allogeneic HCST. Al-Dhekri H; Al-Sum Z; Al-Saud B; Al-Mousa H; Ayas M; Al-Muhsen S; Arnaout R; Al-Seraihy A; Hawwari A; Al-Ghonaium A Clin Immunol; 2012 Apr; 143(1):96-8. PubMed ID: 22342113 [No Abstract] [Full Text] [Related]
10. Lineage-specific chimerism monitoring after allogeneic haematopoietic stem cell transplantation: do we really know what we are measuring? Watson MB; Clouston HJ; Snowden JA; Wilson G; Durkie M; Ward R; Kaur H; Travis D; Barnett D Br J Haematol; 2017 Jan; 176(1):139-141. PubMed ID: 26848116 [No Abstract] [Full Text] [Related]